Brief: Aarti Pharmalabs Expects EBIDTA Growth To Be About 12%-17% Over Next 2-3 Years
26/06/2023 11:36
June 26 (Reuters) - Aarti Pharmalabs Ltd AARP.NS :
* AARTI PHARMALABS LTD - EXPECTING EBIDTA GROWTH TO BE ABOUT
12%-17% OVER NEXT 2-3 YEARS
Source text for Eikon: ID:nNSEbpqlWM
Further company coverage: AARP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aarti Pharmalabs
See all newsBrief: Aarti Pharmalabs Receives Order From Superintendent Of Stamps Gujarat Dated August 29, 2026
Brief: Aarti Pharmalabs June-Quarter Consol Net Profit 761.4 Million Rupees
Brief: Aarti Pharmalabs Declares Dividend Of 2 Rupees Per Share
Brief: Aarti Pharmalabs Ltd Reports Minor Chemical Leak At Unit-VI Tarapur Site On March 22, 2026
Brief: Aarti Pharmalabs Interim Dividend Of 1.50 Rupee Per Equity Share